Summary:
A randomized, multicenter, double-masked, parallel-group study comparing the safety and efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic solution with Timolol Maleate Ophthalmic solution 0.5% in subjects with Open-Angle Glaucoma or Ocular Hypertension.
Qualified Participants Must:
• Be at least 18 years of age
•
Have glaucoma or high eye pressure
•
Be willing and able to complete study requirements